As of 2024-10-07, the Relative Valuation of Integra Lifesciences Holdings Corp (IART) is 24.84 USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.00 USD, the upside of Integra Lifesciences Holdings Corp based on Relative Valuation is 46.1%.
The range of the Relative Valuation is 11.29 - 42.86 USD.
| Range | Selected | |
| Trailing P/E multiples | 37.0x - 44.3x | 41.2x |
| Forward P/E multiples | 23.3x - 33.4x | 28.9x |
| Fair Price | 11.29 - 42.86 | 24.84 |
| Upside | -33.6% - 152.1% | 46.1% |
| Date | P/E |
| 2024-10-04 | 55.76 |
| 2024-10-03 | 55.60 |
| 2024-10-02 | 56.81 |
| 2024-10-01 | 57.40 |
| 2024-09-30 | 59.60 |
| 2024-09-27 | 58.62 |
| 2024-09-26 | 57.31 |
| 2024-09-25 | 56.22 |
| 2024-09-24 | 58.65 |
| 2024-09-23 | 57.53 |
| 2024-09-20 | 57.08 |
| 2024-09-19 | 57.31 |
| 2024-09-18 | 57.50 |
| 2024-09-17 | 56.29 |
| 2024-09-16 | 56.81 |
| 2024-09-13 | 57.31 |
| 2024-09-12 | 57.90 |
| 2024-09-11 | 57.73 |
| 2024-09-10 | 58.13 |
| 2024-09-09 | 57.63 |
| 2024-09-06 | 60.68 |
| 2024-09-05 | 62.95 |
| 2024-09-04 | 63.41 |
| 2024-09-03 | 63.21 |
| 2024-08-30 | 66.72 |
| 2024-08-29 | 67.93 |
| 2024-08-28 | 66.75 |
| 2024-08-27 | 67.31 |
| 2024-08-26 | 68.75 |
| 2024-08-23 | 69.11 |
| 2024-08-22 | 66.82 |
| 2024-08-21 | 68.98 |
| 2024-08-20 | 68.39 |
| 2024-08-19 | 70.69 |
| 2024-08-16 | 70.72 |
| 2024-08-15 | 71.71 |
| 2024-08-14 | 69.87 |
| 2024-08-13 | 71.08 |
| 2024-08-12 | 69.84 |
| 2024-08-09 | 71.51 |
| 2024-08-08 | 71.44 |
| 2024-08-07 | 71.18 |
| 2024-08-06 | 74.72 |
| 2024-08-05 | 73.28 |
| 2024-08-02 | 78.86 |
| 2024-08-01 | 80.73 |
| 2024-07-31 | 81.38 |
| 2024-07-30 | 82.10 |
| 2024-07-29 | 83.38 |
| 2024-07-26 | 103.10 |